NKTR.NASDAQNektar Therapeutics

SCHEDULE: Nantahala Capital Discloses 2.2% Stake in Nektar Therapeutics

Sentiment:

Beneficial Ownership Disclosure

📋All filings for Nektar Therapeutics
🔒Login to Follow

Nantahala Capital Management, along with Wilmot B. Harkey and Daniel Mack, reported a 2.20% beneficial ownership stake in Nektar Therapeutics as of September 30, 2025.

Summary

  • Nantahala Capital Management, LLC, Wilmot B. Harkey, and Daniel Mack (the "Reporting Persons") collectively reported beneficial ownership of 418,522 shares of Nektar Therapeutics common stock.
  • This ownership represents 2.20% of Nektar Therapeutics' outstanding common stock.
  • The shares are held by funds and separately managed accounts under Nantahala Capital Management's control.
  • The Reporting Persons share voting and dispositive power over all 418,522 shares.
  • The filing is an Amendment No. 1 to a Schedule 13G, indicating a change in previously reported ownership or status.

Sentiment

Score: 5

Explanation: The filing is a routine disclosure of passive beneficial ownership, which is generally neutral in sentiment. It does not contain operational or financial performance details of the issuer.

Future Outlook

NA

Industry Context

NA

Stakeholder Impact

  • Shareholders: Provides transparency regarding a significant institutional investor's stake in the company, confirming a passive investment intent.

Key Dates

DateDescription
09/30/2025Date of the event which requires the filing of this statement, representing the 'as of' date for beneficial ownership.
11/14/2025Date the Schedule 13G Amendment No. 1 was signed by the Reporting Persons.

Keywords

Nektar Therapeutics, Nantahala Capital Management, Beneficial Ownership, Schedule 13G, Common Stock, Investment Adviser, Biotechnology

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.